Dermavant is a California-based clinical-stage biopharmaceutical company that develops and commercializes therapeutics for patients with immuno-dermatological conditions.
Business Model:
Revenue: $13.4M
Employees: 51-200
Address: 3780 Kilroy Airport Way
City: Long Beach
State: CA
Zip: 90806
Country: US
Dermavant is a California-based clinical-stage biopharmaceutical company that develops and commercializes therapeutics for patients with immuno-dermatological conditions.
Contact Phone:
+19197673277
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
DRMT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2021 | Debt | $40M | 6/2021 | Private Equity Round | $0 |
Marathon Asset Management Novaquest Capital Management Marathon Asset Management Novaquest Capital Management |
6/2021 | Private Equity Round | 2 | $160M |
Marathon Asset Management Novaquest Capital Management Marathon Asset Management Novaquest Capital Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|